[Hemo- and cardiodynamic changes in arterial hypertension patients as affected by alpha- and beta-adrenergic blockader therapy].
It is shown that treatment of patients with arterial hypertension with obsidan reduces arterial pressure because of a decrease in cardiac output; in treatment with pyroxan the arterial pressure is reduced due to decrease in total peripheral vascular resistance. Combined treatment with alpha- and beta-adrenergic blocking agents allows arterial pressure to be normalized with much lesser doses because the interrelationships of the principal hemodynamic values are normalized.
D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006321:Heart / Q000187:drug effects*; D006334:Heart Function Tests; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists
Izmeneniia gemo- i kardiodinamiki u bol'nykh s arterial'noĭ gipertenzieĭ pod vliianiem terapii al'fa- i beta-adrenoblokatorami.